Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sustained HBsAg and Viral Response in Patients Achieved HBsAg Loss by Interferon Treatment

NCT02336399 is registered in ClinicalTrials.gov with Beijing Ditan Hospital as lead sponsor.

NCT NCT02336399
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02336399 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sustained HBsAg and Viral Response in Patients Achieved HBsAg Loss by Interferon Treatment
Lead sponsor
Beijing Ditan Hospital
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2008
Completion date
December 31, 2021
Enrollment
420 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b